I-test 2: novel retinal biomarkers in pregnancy for early prediction of stillbirth

Project Details

StatusActive
Effective start/end date1/09/2330/09/25

Funding

  • Wellcome Leap Inc: £28,544.88
  • Wellcome Leap Inc: £6,500.21
  • Wellcome Leap Inc: £733,977.88
  • Wellcome Leap Inc: £157,643.67